What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Chemotherapy
Tracy T. Batchelor mainly investigates Internal medicine, Pathology, Cancer research, Surgery and Oncology.
As part of his studies on Internal medicine, Tracy T. Batchelor often connects relevant subjects like Brain tumor.
The concepts of his Pathology study are interwoven with issues in Tumor microenvironment, Microarray analysis techniques, Vascular endothelial growth factor A and Gene expression profiling.
He works on Cancer research which deals in particular with Glioma.
Tracy T. Batchelor works mostly in the field of Surgery, limiting it down to topics relating to Lymphoma and, in certain cases, Malignancy, Biopsy and CSF albumin, as a part of the same area of interest.
His Oncology research includes elements of Glioblastoma, Clinical trial, Immunology and Dacarbazine.
His most cited work include:
- AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients (1520 citations)
- Angiogenesis in brain tumours (995 citations)
- Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. (823 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Internal medicine, Oncology, Cancer research, Pathology and Glioma.
His Internal medicine research focuses on Surgery and how it connects with Gastroenterology.
His studies in Oncology integrate themes in fields like Cancer, Clinical trial, Phases of clinical research, Cediranib and Glioblastoma.
He has researched Cancer research in several fields, including Recurrent glioblastoma and In vivo.
Tracy T. Batchelor has included themes like Magnetic resonance imaging, Angiogenesis and Perfusion in his Pathology study.
His Glioma study also includes fields such as
- Bevacizumab which connect with Vascular endothelial growth factor,
- Pharmacology which connect with Toxicity.
He most often published in these fields:
- Internal medicine (40.41%)
- Oncology (31.37%)
- Cancer research (22.51%)
What were the highlights of his more recent work (between 2017-2021)?
- Cancer research (22.51%)
- Internal medicine (40.41%)
- Glioma (20.85%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Cancer research, Internal medicine, Glioma, Oncology and Temozolomide.
Tracy T. Batchelor combines subjects such as Exome sequencing, Cancer, Primary central nervous system lymphoma, Kinase and In vivo with his study of Cancer research.
In his papers, Tracy T. Batchelor integrates diverse fields, such as Internal medicine and In patient.
The various areas that Tracy T. Batchelor examines in his Glioma study include Isocitrate dehydrogenase, Thalamus, Mutant, Fluid-attenuated inversion recovery and Brain tumor.
His Oncology study integrates concerns from other disciplines, such as Bevacizumab, Chemotherapy, Toxicity, Radiation therapy and Glioblastoma.
His Radiation therapy research includes themes of Disease and Lymphoma.
Between 2017 and 2021, his most popular works were:
- An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma (341 citations)
- Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq (206 citations)
- cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant (123 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
His primary areas of investigation include Cancer research, Internal medicine, Glioma, Oncology and Temozolomide.
The study incorporates disciplines such as Exome sequencing, Mutation, Primary central nervous system lymphoma, Kinase and In vivo in addition to Cancer research.
As part of his studies on Internal medicine, he often connects relevant areas like Radiography.
His research in Glioma focuses on subjects like Isocitrate dehydrogenase, which are connected to IDH1 and Mutant.
His studies deal with areas such as Clinical trial, Toxicity, Bevacizumab, Radiation therapy and Glioblastoma as well as Oncology.
His Temozolomide research is multidisciplinary, incorporating elements of T cell, Cancer and DNA mismatch repair.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
